Literature DB >> 31199986

SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer.

Xue Wu1, Zhenlong Xin2, Zheng Zou3, Chenxi Lu4, Zihao Yu4, Sizhe Feng5, Pengyu Pan5, Guangzhi Hao5, Yushu Dong6, Yang Yang7.   

Abstract

The epithelial-mesenchymal transition (EMT) is a process of cell transformation under certain physiological and pathological states in which epithelial cells are transformed into mesenchymal cells with fibroblast-like properties, which confers upon them the increased invasion and migration capabilities of cancer cells. Previous studies have demonstrated that SRY-related high-mobility-group box 4 (Sox4) protein coordinates EMT-related pathways and EMT-related transcription factors, thereby regulating the EMT process. The focus of this review is to evaluate recent advances regarding the role of Sox4 protein in the cancer EMT. First, we provide an overview of the general background of Sox4 (structure and function) and the EMT in cancer. Next, we introduce the interactions between Sox4 protein and various factors during cancer EMT. Finally, we suggest directions for future investigations. In general, the information compiled in this paper should serve as a comprehensive repository of information on the subject matter and contribute to the design of other research and future efforts to develop therapeutic strategies that target the Sox4 protein.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Epithelial-mesenchymal transition; SRY-related high-mobility-group box 4

Year:  2019        PMID: 31199986     DOI: 10.1016/j.semcancer.2019.06.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  7 in total

1.  Retracted Article: Long noncoding RNA ANRIL knockdown increases sensitivity of non-small cell lung cancer to cisplatin by regulating the miR-656-3p/SOX4 axis.

Authors:  Xianfang Wang; Jun Shi; Ying Chen; Caihong Wang; Huifang Shi; Xuefang Xie
Journal:  RSC Adv       Date:  2019-11-26       Impact factor: 4.036

2.  METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.

Authors:  Xiaoxiang Chen; Mu Xu; Xueni Xu; Kaixuan Zeng; Xiangxiang Liu; Bei Pan; Chenmeng Li; Li Sun; Jian Qin; Tao Xu; Bangshun He; Yuqin Pan; Huilin Sun; Shukui Wang
Journal:  Mol Cancer       Date:  2020-06-17       Impact factor: 27.401

Review 3.  Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.

Authors:  Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

Review 4.  MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Hui Li Ang; Ebrahim Rahmani Moghadam; Shima Mohammadi; Vahideh Zarrin; Kiavash Hushmandi; Saeed Samarghandian; Ali Zarrabi; Masoud Najafi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-07-12

Review 5.  Sex-Determining Region Y Chromosome-Related High-Mobility-Group Box 10 in Cancer: A Potential Therapeutic Target.

Authors:  Liming Yu; Fan Peng; Xue Dong; Ying Chen; Dongdong Sun; Shuai Jiang; Chao Deng
Journal:  Front Cell Dev Biol       Date:  2020-12-03

6.  Transcriptomic and immunologic implications of the epithelial-mesenchymal transition model reveal a novel role of SFTA2 in prognosis of non-small-cell lung carcinoma.

Authors:  Na Li; Zhanqiang Zhai; Yuanbiao Chen; Xiaofeng Li
Journal:  Front Genet       Date:  2022-08-26       Impact factor: 4.772

Review 7.  Mechanism underlying circRNA dysregulation in the TME of digestive system cancer.

Authors:  Zeyu Wu; Xiao Yu; Shuijun Zhang; Yuting He; Wenzhi Guo
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.